Related Experiment Videos
Cysteine protease inhibitors block schistosome hemoglobin degradation in vitro and decrease worm burden and egg
M M Wasilewski1, K C Lim, J Phillips
1Department of Medicine, University of California, San Francisco 94143, USA.
Molecular and Biochemical Parasitology
|October 30, 1996
Summary
Cysteine protease inhibitors halt schistosome hemoglobin breakdown, leading to parasite death. In vivo studies show reduced worm burden and egg production in treated mice, identifying specific protease targets.
Area of Science:
- Parasitology
- Biochemistry
- Drug Discovery
Background:
- Schistosome parasites rely on host hemoglobin for nutrition.
- Hemoglobin degradation is thought to involve cysteine and aspartyl proteases.
Purpose of the Study:
- To investigate the role of cysteine proteases in schistosome hemoglobin metabolism.
- To evaluate the therapeutic potential of cysteine protease inhibitors against schistosomes.
Main Methods:
- In vitro inhibition of hemoglobin degradation using two distinct cysteine protease inhibitors.
- In vivo treatment of infected mice with inhibitors.
- Biotinylation of inhibitors to identify specific protease targets.
Main Results:
- Cysteine protease inhibitors effectively blocked schistosome hemoglobin degradation in vitro.
- Inhibitor treatment led to the death of developing schistosomes.
- Infected mice treated with inhibitors showed reduced worm burden, liver enlargement, and egg production.
- Histopathology revealed a diminished immune response to eggs, suggesting delayed egg production.
Conclusions:
- Cysteine proteases are crucial for schistosome hemoglobin utilization.
- Cysteine protease inhibitors demonstrate therapeutic efficacy against schistosome infection.
- Targeting schistosome cysteine proteases offers a promising strategy for schistosomiasis treatment.